Biotech
🔥 Lilly Just Paid Up to $2.88 Billion for a Startup With Zero Approved Drugs
Eli Lilly is paying up to $2.88 billion for Merida Biosciences, a 16-month-old startup whose lead autoimmune drug is still in Phase 1.
Eli Lilly is paying up to $2.88 billion for Merida Biosciences, a 16-month-old startup whose lead autoimmune drug is still in Phase 1.
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
SAP just closed its €1B+ acquisition of Prior Labs, an 18-month-old Freiburg lab building tabular foundation models — AI for spreadsheets and databases, not chatbots.